-

SHAREHOLDER ALERT: Robbins LLP Announces That Amdocs Limited (DOX) is Being Sued for Misleading Shareholders

SAN DIEGO & CHESTERFIELD, Mo.--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP announces that a purchaser of Amdocs Limited (NYSE: DOX) filed a class action complaint against the Company and its officers and directors for alleged violations of the Securities Exchange Act of 1934 between January 29, 2021 and March 30, 2021. Amdocs provides software and services to the communications, cable and satellite, entertainment, and media industry service providers worldwide.

If you suffered a loss due to Amdocs Limited's misconduct, click here.

Amdocs Limited (DOX) Misstated its Financials

According to the complaint, Amdocs conducted its 2021 Annual General Meeting ("AGM") on January 29, 2021, wherein all ten directors were elected to the Board, the quarterly dividend rate increase was approved, Amdocs' Consolidated Financial Statements for FY2020 was approved, and Ernst & Young was approved as the Company's independent registered public accounting firm for FY2021. The Notice of the 2021 AGM incorporated the Company's annual report on Form 20-F for the period ended September 30, 2020 (FY20 20-F), and directed shareholders to consult it for additional information. The FY20 20-F claimed Amdocs' U.S. business had been increasing, that its cash flow and lines of credit would "provide sufficient resources to meet our operational needs," and stated that it had zero debt outstanding as of September 30, 2019.

On February 2, 2021, Amdocs issued a press release announcing its first quarter FY2021 financial results for the interim period ended December 31, 2020. The Company's President and CEO touted Amdocs' "best ever performance in North America" and increased profitability. The release affirmed previously provided financial guidance, stating, "We remain on-track with our guidance to deliver accelerated growth in fiscal 2020 … we continue to expect a stronger second half as we execute on our strategy…" A conference call with investors and the Company's SEC filings on February 16, confirmed these statements.

Despite these positive affirmations, Amdocs had failed to inform investors that it had been losing customers and its U.S. business had been declining, that it had borrowed undisclosed sums to meet its capital needs, concealed the restrictions on the cash it held, and that it had been overstating its profits by up to 50%. The truth was revealed on March 30, 2021, when Jehoshaphat Research issued a report "reveal[ing] the results of a months-long investigation into what [that firm] believe[s] is a massive financial deception taking place at Amdocs." On this news, Amdocs stock fell more than 10%, closing at $70.15 on March 31, 2021.

If you purchased shares of Amdocs Limited (DOX) between January 29, 2021 and March 30, 2021, you have until June 8, 2021, to ask the court to appoint you lead plaintiff for the class.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:
Lauren Levi
(800) 350-6003
llevi@robbinsllp.com
Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. To be notified if a class action against Amdocs Limited settles or to receive free alerts about companies engaged in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Lauren Levi
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
llevi@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Investor Notice: Robbins LLP Informs Investors of the Immutep Limited Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Immutep Limited American Depository Receipts (NASDAQ: IMMP) between March 24, 2025 and March 12, 2026. Immutep is an Australian-based biotechnology company focused on developing Lymphocyte Activation Gene-3 (LAG-3) related immunotherapies for cancer and autoimmune diseases. The company’s product pipeline includes TACTI-004, which is in phase II...

Robbins LLP Reminds DRVN Stockholders of the Pending Class Action Lawsuit; Harmed Investors Should Contact the Firm for Information About the Class Action Against Driven Brands Holdings Inc.

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Driven Brands Holdings Inc. (NASDAQ: DRVN) common stock between May 9, 2023 and February 24, 2026. Driven Brands is the largest automotive services company in North America, operating in approximately 4,900 locations across more than 15 countries. The Company provides maintenance, car wash, collision, and glass services, and operates as a holdi...

Investor Notice: Robbins LLP Informs Investors of the FS KKR Capital Corp. Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired FS KKR Capital (NYSE: FSK) securities between May 8, 2024 and February 25, 2026. FS KKR Capital is a private credit firm, also known as Business Development Company, which specializes in making private loans to companies.For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.The Allegations: Ro...
Back to Newsroom